Senti Biosciences Holdings, Inc. (SNTI) Operating income 2021–2025
Senti Biosciences Holdings, Inc. (SNTI) annual operating income history from SEC filings — each fiscal year as reported.
-$68.8MFY2025 · since FY2021: -$40.4M → -$68.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$68.8M | -12.7% |
| FY2024 | -$61.0M | +34.2% |
| FY2023 | -$92.7M | -49.4% |
| FY2022 | -$62.1M | -53.5% |
| FY2021 | -$40.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SNTI financial trends
SNTI RevenueSNTI Net incomeSNTI Net marginSNTI Gross profitSNTI Gross marginSNTI Operating marginSNTI Operating cash flowSNTI Free cash flowSNTI Capital expendituresSNTI Return on equitySNTI Stock buybacksSNTI Dividends paidSNTI Total assetsSNTI Total liabilitiesSNTI Shareholders’ equitySNTI overview →